SEC ownership of PROCTER & GAMBLE Co

Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0000080424.

Comparable stake leader

VANGUARD CAPITAL MANAGEMENT LLC

Disclosed value leader

BlackRock, Inc.

Comparable rows

50/50

Latest evidence

09 Jun 2026

Ownership snapshot CIK-linked ownership evidence from parsed SEC filings. 3 signals
Comparable ownership rows
50 of 50
Meaning: Rows with safely comparable ownership %
Latest 13D/G holder
VANGUARD CAPITAL MANAGEMENT LLC
Source: Latest parsed Schedule 13D/G stake
Latest parsed ownership date
09 Jun 2026
Freshness: Most recent filing date in this holder set
Issuer Names, identifiers, and filing context for this profile. 2 identity fields
Issuer CIK
0000080424
Issuer location
Cincinnati, OH

Ownership snapshot

Top shareholders of PROCTER & GAMBLE Co (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
VANGUARD CAPITAL MANAGEME...
Disclosed value leader
BlackRock, Inc.
Comparable rows
50/50
Latest evidence
09 Jun 2026
13D/G 13F 3/4/5 Lead comparable stake: 7.5% 13D/G row: VANGUARD CAPITAL MANAGEMENT LLC Showing 1-8 of 50 holder rows.

Quick read

VANGUARD CAPITAL MANAGEMENT LLC leads the comparable SEC ownership view at 7.5%.

50 of 50 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens VANGUARD CAPITAL MANAGEMENT LLC's linked filing trail.
Comparable ownership Top 5
VANGUARD CAPITAL MANAGEMENT LLC 7.5%
Patricia A. Woertz 0%
Terry J. Lundgren 0%
Joseph Jimenez 0%
Paul Gama 0%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-8 of 50 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
VANGUARD CAPITAL MANAGEMENT LLC
13D/G 13F
Vanguard Capital Management · Company
7.5%
$25,249,566,655
174,810,071 shares
$0 31 Mar 2026
Patricia A. Woertz
3/4/5
Director
0%
$7,920,431
51,549 shares
14 Oct 2025
Terry J. Lundgren
3/4/5
Director
0%
$6,754,252
43,959 shares
14 Oct 2025
Joseph Jimenez
3/4/5
Director
0%
$5,346,601
37,016 shares
09 Jun 2026
Paul Gama
3/4/5
CEO- Health Care
0%
$5,332,442
36,918 shares
01 Apr 2026
Christine M. McCarthy
3/4/5
Director
0%
$2,529,528
17,513 shares
09 Jun 2026
Amy Chang
3/4/5
Director
0%
$2,606,118
16,961 shares
14 Oct 2025
Christopher J. Kempczinski
3/4/5
Director
0%
$1,674,860
11,596 shares
09 Jun 2026
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Forms 3/4/5 flow

Insider trading overview

Net insider flow leans to selling over the last 12 months. Net value: -$81,148,781.

Buys
$0
Insiders: 0
Sells
$81,148,781
Insiders: 13
Net
-$81,148,781
Shares: -512,824
Window
Last 12 months
4 rolling buckets
Buy value Sell value
Shares: 0 Shares: 512,824
Window (months) Buy shares Sell shares Buy value Sell value Net value
0-3 0 0 $0 $0 $0
3-6 0 348,618 $0 $55,462,363 -$55,462,363
6-9 0 32,562 $0 $4,955,076 -$4,955,076
9-12 0 131,644 $0 $20,731,341 -$20,731,341

Reporting owners

Insider holders from Forms 3/4/5

Showing 1-20 of 42 reporting-owner rows connected to PROCTER & GAMBLE Co. Open a relationship link for the CIK-to-CIK filing trail.

Rows
42
Largest Forms 3/4/5 holder
Nelson Peltz
Net 12M change
-$81,148,782
Latest report
09 Jun 2026
Name Relationship Holdings Value Past Year Net Change Change % Valuation Report Date
Nelson Peltz Director $787,266,736 Mixed 31 Aug 2021
Jon R. Moeller Exec. Chairman of the Board, Director $62,004,055 -$36,208,464 -37% Mixed 11 Feb 2026
David S. Taylor Executive Chairman, Director $42,859,403 Mixed 25 Apr 2022
Marc S. Pritchard Chief Brand Officer $36,623,474 -$16,044,680 -30% Mixed 23 Jan 2026
MaryLynn FergusonMchugh CEO - Family Care & P&G Ventur $28,771,352 Mixed 17 Aug 2021
Shailesh Jejurikar Chief Operating Officer, Director $13,122,709 -$2,657,489 -17% Mixed 03 Dec 2025
W. James McNerney Jr. Director $12,843,331 Mixed 14 Sep 2021
Steven D. Bishop CEO - Health Care $12,290,541 Mixed 11 May 2021
Jennifer L. Davis CEO - Health Care $11,968,734 -$1,843,177 -13% Mixed 03 Dec 2025
Angela F. Braly Director $9,679,531 Mixed 11 Jun 2024
Andre Schulten Chief Financial Officer $9,116,492 -$2,477,832 -21% Mixed 03 Dec 2025
Mr. Aguilar Moses Chf Rsch, Dev & Innov Officer $8,656,953 -$2,461,609 -22% Mixed 13 Feb 2026
Patricia A. Woertz Director $7,920,431 Mixed 14 Oct 2025
Sundar G. Raman CEO-Fabric & Home Care $7,714,313 -$1,511,050 -16% Mixed 03 Dec 2025
R. Alexandra Keith CEO - Beauty $7,019,010 -$2,156,107 -23% Mixed 02 Oct 2025
Terry J. Lundgren Director $6,754,252 Mixed 14 Oct 2025
Susan Street Whaley Chief Legal Officer & Secy $6,106,178 -$1,781,771 -23% Mixed 19 Feb 2026
Gary A. Coombe CEO - Grooming $6,100,375 -$8,009,414 -57% Mixed 12 Feb 2026
Deborah P. Majoras Chief Legal Officer & Secy $5,863,052 Mixed 01 Mar 2022
Ma. Fatima Francisco CEO - Baby, Fem & Family Care $5,608,997 -$3,612,391 -39% Mixed 27 Feb 2026

Recent insider transactions for PROCTER & GAMBLE Co

Showing up to 300 recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % SEC-reported value SEC-reported price Shares Shares owned Date Ownership
Robert Jones Portman PG Common Stock Award 1% 51 5,155 09 Jun 2026 Direct
Ashley McEvoy PG Common Stock Award 3.49% 202 5,986 09 Jun 2026 Direct
Christine M. McCarthy PG Common Stock Award 1.47% 253 17,513 09 Jun 2026 Direct
Christopher J. Kempczinski PG Common Stock Award 2.28% 258 11,596 09 Jun 2026 Direct
Joseph Jimenez PG Common Stock Award 0.87% 320 37,016 09 Jun 2026 Direct
Craig Arnold PG Common Stock Award 7.75% 202 2,808 09 Jun 2026 Direct
Robert Jones Portman PG Common Stock Award 0.98% 49 5,066 10 Mar 2026 Direct
Ashley McEvoy PG Common Stock Award 2.88% 161 5,751 10 Mar 2026 Direct
Christine M. McCarthy PG Common Stock Award 1.24% 209 17,129 10 Mar 2026 Direct
Christopher J. Kempczinski PG Common Stock Award 1.82% 201 11,251 10 Mar 2026 Direct
Joseph Jimenez PG Common Stock Award 0.75% 273 36,512 10 Mar 2026 Direct
Craig Arnold PG Common Stock Award 6.64% 161 2,586 10 Mar 2026 Direct
Ma. Fatima Francisco PG Common Stock Sale -84.4% $917,199 $165.29 -5,549 1,029 27 Feb 2026 Direct
Susan Street Whaley PG Common Stock Sale -5.65% $288,454 $159.46 -1,809 30,215 19 Feb 2026 Direct
Ma. Fatima Francisco PG Restricted Stock Units Award 6.85% 57 889 17 Feb 2026 Direct
Susan Street Whaley PG Restricted Stock Units Award 21.4% 11.49 65 17 Feb 2026 Direct
Mr. Aguilar Moses PG Common Stock Sale -25.3% $2,461,609 $162.28 -15,169 44,735 13 Feb 2026 Direct
Mr. Aguilar Moses PG Common Stock Options Exercise 33.9% 15,169 59,904 13 Feb 2026 Direct
Mr. Aguilar Moses PG Stock Option (Right to Buy) Options Exercise -100% -15,169 0 13 Feb 2026 Direct
Jon R. Moeller PG Common Stock Sale -33.7% $26,354,361 $162.45 -162,232 319,385 12 Feb 2026 Direct
Jon R. Moeller PG Common Stock Options Exercise 50.8% 162,232 481,617 12 Feb 2026 Direct
Jon R. Moeller PG Stock Option (Right to Buy) Options Exercise -100% -162,232 0 12 Feb 2026 Direct
Gary A. Coombe PG Common Stock Sale -50.8% $5,859,002 $162.33 -36,093 34,994 12 Feb 2026 Direct
Gary A. Coombe PG Common Stock Options Exercise 103.1% 36,093 71,087 12 Feb 2026 Direct
Gary A. Coombe PG Stock Option (Right to Buy) Options Exercise -50% -36,093 36,093 12 Feb 2026 Direct
Balaji Purushothaman PG Common Stock Sale -50.4% $2,056,287 $160.31 -12,827 12,639 11 Feb 2026 Direct
Balaji Purushothaman PG Common Stock Options Exercise 101.5% 12,827 25,466 11 Feb 2026 Direct
Balaji Purushothaman PG Stock Option (Right to Buy) Options Exercise -100% -12,827 0 11 Feb 2026 Direct
Jon R. Moeller PG Common Stock Sale -3.34% $1,765,760 $160.00 -11,036 319,385 11 Feb 2026 Direct
Jon R. Moeller PG Common Stock Options Exercise 3.46% 11,036 330,421 11 Feb 2026 Direct
Jon R. Moeller PG Stock Option (Right to Buy) Options Exercise -6.37% -11,036 162,232 11 Feb 2026 Direct
Ma. Fatima Francisco PG Common Stock Sale -54.9% $1,264,000 $158.00 -8,000 6,571 04 Feb 2026 Direct
Marc S. Pritchard PG Common Stock Sale -34.4% $14,495,690 $151.15 -95,903 182,607 23 Jan 2026 Direct
Marc S. Pritchard PG Common Stock Options Exercise 52.5% 95,903 278,510 23 Jan 2026 Direct
Marc S. Pritchard PG Stock Option (Right to Buy) Options Exercise -100% -95,903 0 23 Jan 2026 Direct
Robert Jones Portman PG Common Stock Award 1.1% 54 4,984 09 Dec 2025 Direct
Ashley McEvoy PG Common Stock Award 4.02% 215 5,563 09 Dec 2025 Direct
Christine M. McCarthy PG Common Stock Award 1.63% 269 16,809 09 Dec 2025 Direct
Christopher J. Kempczinski PG Common Stock Award 2.43% 260 10,978 09 Dec 2025 Direct
Joseph Jimenez PG Common Stock Award 0.95% 341 36,084 09 Dec 2025 Direct
Craig Arnold PG Common Stock Award 9.8% 215 2,409 09 Dec 2025 Direct
Jon R. Moeller PG Common Stock Options Exercise 0.05% 159 319,695 03 Dec 2025 Direct
Jon R. Moeller PG Common Stock Tax liability -0.32% -1,029 319,385 03 Dec 2025 Direct
Jon R. Moeller PG Restricted Stock Units Options Exercise -7.09% -159 2,084 03 Dec 2025 Direct
Susan Street Whaley PG Common Stock Tax liability -0.17% -54.39 31,902 03 Dec 2025 Direct
Susan Street Whaley PG Common Stock Options Exercise 0.17% 54.39 31,957 03 Dec 2025 Direct
Susan Street Whaley PG Restricted Stock Units Options Exercise -7.05% -54.39 718 03 Dec 2025 Direct
Andre Schulten PG Common Stock Options Exercise 0.17% 88.63 53,544 03 Dec 2025 Direct
Andre Schulten PG Common Stock Tax liability -1.61% -873 53,386 03 Dec 2025 Direct
Andre Schulten PG Restricted Stock Units Options Exercise -7.03% -88.63 1,171 03 Dec 2025 Direct
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .